Search by Drug Name or NDC

    NDC 00067-6296-01 LAMISIL 0.84 g/125mL Details

    LAMISIL 0.84 g/125mL

    LAMISIL is a TOPICAL AEROSOL, SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is TERBINAFINE HYDROCHLORIDE.

    Product Information

    NDC 00067-6296
    Product ID 0067-6296_54dd4021-d70c-426b-9506-1d1f1819782f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name LAMISIL
    Proprietary Name Suffix AT
    Non-Proprietary Name TERBINAFINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form AEROSOL, SPRAY
    Route TOPICAL
    Active Ingredient Strength 0.84
    Active Ingredient Units g/125mL
    Substance Name TERBINAFINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Allylamine Antifungal [EPC], Allylamine [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021124
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-6296-01 (00067629601)

    NDC Package Code 0067-6296-01
    Billing NDC 00067629601
    Package 125 mL in 1 CAN (0067-6296-01)
    Marketing Start Date 2018-03-07
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 03659e44-7406-4064-8141-f552315dd05f Details

    Revised: 8/2021